Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05470127Not ApplicableRecruiting

Evaluation of the Performance of a Novel Prostate Biopsy System Compared With Standard of Care Biopsy Needle on Quantitative and Qualitative Tissue Parameters

Role: lead

NCT06830265Not ApplicableNot Yet Recruiting

Comparing Standard of Care Biopsy System to a Novel Biopsy Needle System by Computational Pathologic Analysis

Role: lead

NCT06550960Not ApplicableNot Yet Recruiting

Evaluation of SureCore Plus Biopsy System

Role: lead

NCT04982536Not ApplicableUnknown

Assessment of VMCore Biopsy Versus Standard of Care Biopsy

Role: lead

NCT04982120Not ApplicableUnknown

Use of Repris Needle in Bladder Injection

Role: lead

All 5 trials loaded